Population
Normal and failing hearts (chronic heart failure)
Design
Review
Authors
Loading...
Metabolic shifts in advanced HF identify potential targets; leaves open whether modulating them alters outcomes in trials.
This review highlights that while myocardial substrate selection is relatively normal in early heart failure, advanced stages are characterized by significant metabolic shifts including downregulated fatty acid oxidation and increased glycolysis, which may serve as therapeutic targets.
Stanley et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: